Support and Resistance Levels
Past performance
About Suraksha Diagnostic Ltd **Suraksha Diagnostic Limited: Company Overview**
Suraksha Diagnostic Limited was established in 2005 as a private limited company in Kolkata, West Bengal. It transitioned into a public limited entity in 2024. The company operates diagnostic centers primarily across East India, offering a diverse range of pathology and radiology testing services, alongside omnichannel medical consultations via both online and offline platforms. With 43 diagnostic centers equipped with 120 polyclinic chambers, Suraksha hosts a robust network of over 750 doctors.
Suraksha boasts a comprehensive testing menu, offering 788 routine pathology tests, including basic biochemistry and hematology, as well as 647 advanced pathology tests like molecular pathology. Its radiology portfolio comprises 748 basic tests (X-rays, USGs, CT scans) and 104 advanced radiology tests such as specialized CT and MRI scans. The company's facilities continually expand, offering cutting-edge equipment like 3T MRI and 128 CT launched in New Town in 2023, emphasizing its commitment to innovation in diagnostic services.
The company's growth trajectory has been marked by strategic expansions and acquisitions. Starting with its Kestopur center in 2007, it scaled operations to include 25 centers by 2016 and acquired Sunwell Diagnostic Private Limited in 2017. It further expanded through a public-private partnership with the Government of Meghalaya in 2019 and acquired two diagnostic centers in Kolkata in 2020. These initiatives underline Suraksha’s aggressive regional footprint and operational scale.
Suraksha Diagnostic Limited is set to launch a public issue offering up to 19,189,330 equity shares through an Offer for Sale, providing potential investors an opportunity to participate in the company’s growth story. Its established presence, innovative services, and continuous expansion make it an attractive investment prospect for traders interested in the diagnostic and healthcare sector.